Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1370237 | Bioorganic & Medicinal Chemistry Letters | 2011 | 6 Pages |
Abstract
A novel class of pan-Pim kinase inhibitors was designed by modifying the CK2 inhibitor CX-4945. Introduction of a triazole or secondary amide functionality on the C-7 position and 2′-halogenoanilines on C-5 resulted in potent inhibitors of the Pim-1 and Pim-2 isoforms, with many analogs active at single digit nanomolar concentrations. The molecules inhibited the phosphorylation at Serine 112 of the apoptosis effector BAD, and had potent antiproliferative effects on the AML cell line MV-4-11 (IC50 <30 nM). This work delivers an excellent lead-optimization platform for Pim targeting anticancer therapies.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Fabrice Pierre, Eric Stefan, Anne-Sophie Nédellec, Marie-Claire Chevrel, Collin F. Regan, Adam Siddiqui-Jain, Diwata Macalino, Nicole Streiner, Denis Drygin, Mustapha Haddach, Sean E. O’Brien, Kenna Anderes, David M. Ryckman,